Serum levels of interleukin-2 differ between prostate cancer and benign prostatic hyperplasia

• Main Authors: Otavio T Nobrega (Author), William K El-Chaer (Author), Gleiciane G Avelar (Author), Audrey C Tonet-Furioso (Author), Diego Ignacio V Perez (Author), Clayton F Moraes (Author)
• Format: Book
• Published: Sociedade Brasileira de Patologia Clínica, 2022-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

ABSTRACT Objective Investigation onthe systemic inflammatory profile ofpatients affected by prostate cancer (PCa) or prostatic hyperplasia (BPH) may contribute to characterize the pathological profile as well as enable identification of markers and promote alternatives for appropriate, less invasive...